We report our experience in the treatment of renal staghorn stones. 74 patients were treated with PCNL followed, when necessary, by one or more ESWL treatments for residual fragments, achieving a stone-free status in 64/74 patients (86.5%). Treatment with ESWL monotherapy (6 cases) resulted in a stone-free status in 3 patients (50%). According to our experience, PCNL followed by ESWL, is the most adequate treatment for staghorn kidney stones. We reserve PCNL with multiple percutaneous access and ESWL monotherapy for selected patients.
Read full abstract